The Company Ionis Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 12.12 Billions, having an equity of $ 489.09 Millions.
With a total of 817 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.
In the last 12 months the Company had a revenue of $ 943.71 Millions, which generated a loss in the amount of $ -381.39 Millions.
As for its main indicators, the Company has a P/E ratio of -31.77, a P/BV ratio of 24.77 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker IONS.